Quest Diagnostics (DGX) declares $0.53/share quarterly dividend, in line with previous. Forward yield 2.18% Payable July 22; for shareholders of record Jul
OXFD earnings call for the period ending March 31, 2019.
The diagnostics information services company provided an upside surprise on both the top and bottom lines.
It has been about a month since the last earnings report for Quest Diagnostics (DGX). Shares have added about 3% in that time frame, outperforming the S&P 500.Will the recent...
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Quest Diagnostics (DGX) and Chemed (CHE). But which of these two stocks is more...
Wednesday, April 24, 2019The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks,...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Buy||Strong Buy||Strong Buy||Strong Buy||BUY|
|Summary||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Outside Up||1D||Current|
|Deliberation Bearish||1W||2||May 05, 2019|
|Bullish Engulfing||5H||2||May 23, 2019 03:00PM|
|Three Outside Up||1W||3||Apr 28, 2019|
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|Cyprus Securities and Exchange Commission (Cyprus), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia)||$200||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.